Roughly 3200 patients in Alzheimers trials and their families were jolted when they found out an experimental treatment from Biogen was a failure. Now theyre faced with another question What now httpsbuff.ly2uDAC95Â

Roughly 3,200 patients in Alzheimer’s trials and their families were jolted when they found out an experimental treatment from Biogen was a failure. Now, they’re faced with another question: What now? https://buff.ly/2uDAC95 

Roughly 3,200 patients in Alzheimer’s trials and their families were jolted when they found out an experimental treatment from Biogen was a failure. Now, they’re faced with another question: What now? https://buff.ly/2uDAC95 

More From BioPortfolio on "Roughly 3,200 patients in Alzheimer’s trials and their families were jolted when they found out an experimental treatment from Biogen was a failure. Now, they’re faced with another question: What now? https://buff.ly/2uDAC95 "